Palisade Bio (PALI) Depreciation and Depletion (2023 - 2025)
Palisade Bio (PALI) reported Depreciation and Depletion of $1000.0 for Q3 2025, little changed year-over-year from $1000.0 in Q3 2024, and little changed on a QoQ basis from $1000.0 in Q2 2025.
Palisade Bio (PALI) has 3 years of Depreciation and Depletion data on file, last reported at $1000.0 in Q3 2025.
- Quarterly Depreciation and Depletion changed 0.0% year-over-year to $1000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $2000.0 (down 33.33% YoY) and the FY2025 annual result came in at $3000.0, changed 0.0% from the prior year.
- Depreciation and Depletion was little changed at $1000.0 in Q3 2025 per PALI's latest filing, from $1000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $2000.0 in Q2 2023 and bottomed at $1000.0 in Q1 2023.
- The 3-year median for Depreciation and Depletion is $1000.0 (2023), against an average of $1111.1.
- Peak annual rise in Depreciation and Depletion reached 0.0% in 2024, while the deepest fall reached 50.0% in 2024.
- Tracing PALI's Depreciation and Depletion over 3 years: stood at $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
- Per Business Quant, the three latest PALI Depreciation and Depletion figures stand at $1000.0 (Q3 2025), $1000.0 (Q2 2025), and $1000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |